You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-EGFR antibody (ab2430)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab2430? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab2430 has been referenced in 14 publications.

  1. Keereweer S et al. Dual wavelength tumor targeting for detection of hypopharyngeal cancer using near-infrared optical imaging in an animal model. Int J Cancer : (2012). PubMed: 22234729
  2. Kong Q et al. Migration of connective tissue-derived cells is mediated by ultra-low concentration gradient fields of EGF. Exp Cell Res 317:1491-502 (2011). In-Cell ELISA; Cow. PubMed: 21536028
  3. Sakamoto K et al. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer. Oncogene 29:5359-69 (2010). IHC-P; Mouse. PubMed: 20639901
  4. Qayum N et al. Tumor vascular changes mediated by inhibition of oncogenic signaling. Cancer Res 69:6347-54 (2009). IHC. PubMed: 19622766
  5. Vlotides G et al. Fibroblast growth factor-2 autofeedback regulation in pituitary folliculostellate TtT/GF cells. Endocrinology 150:3252-8 (2009). IP. PubMed: 19359387
  6. Scaltriti M et al. Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity. Oncogene 28:803-14 (2009). WB. PubMed: 19060928
  7. Izal-Azcárate A et al. Immunohistochemical characterization of the rat carotid body. Respir Physiol Neurobiol 161:95-9 (2008). PubMed: 18280799
  8. Terry G et al. The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions. Br J Cancer 96:110-7 (2007). PubMed: 17164758
  9. Fru KN et al. Regulation of granulosa cell proliferation and EGF-like ligands during the periovulatory interval in monkeys. Hum Reprod 22:1247-52 (2007). PubMed: 17293344
  10. Erschbamer M et al. Inhibiting epidermal growth factor receptor improves structural, locomotor, sensory, and bladder recovery from experimental spinal cord injury. J Neurosci 27:6428-35 (2007). PubMed: 17567803
  11. Oh KB et al. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation. Oncogene 26:5950-9 (2007). PubMed: 17369844
  12. Shah T et al. Epidermal growth factor receptor expression and activation in neuroendocrine tumours. J Neuroendocrinol 18:355-60 (2006). PubMed: 16629834
  13. Feistritzer C et al. Endothelial protein C receptor-dependent inhibition of migration of human lymphocytes by protein C involves epidermal growth factor receptor. J Immunol 176:1019-25 (2006). PubMed: 16393989
  14. Friedmann BJ et al. Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment. Mol Cancer Ther 5:209-18 (2006). WB, IP; Human, Rat. PubMed: 16505093

Publishing research using ab2430? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"